Correlation Between Day One and Praxis Precision

Can any of the company-specific risk be diversified away by investing in both Day One and Praxis Precision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Praxis Precision into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Praxis Precision Medicines, you can compare the effects of market volatilities on Day One and Praxis Precision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Praxis Precision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Praxis Precision.

Diversification Opportunities for Day One and Praxis Precision

0.29

Correlation Coefficient

Day One  Praxis Precision

Modest diversification

The 3 months correlation between Day and Praxis is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Praxis Precision Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Praxis Precision Med and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Praxis Precision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Praxis Precision Med has no effect on the direction of Day One i.e., Day One and Praxis Precision go up and down completely randomly.

Pair Corralation between Day One and Praxis Precision

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Praxis Precision. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.66 times less risky than Praxis Precision. The stock trades about -0.03 of its potential returns per unit of risk. The Praxis Precision Medicines is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  5,829  in Praxis Precision Medicines on September 15, 2024 and sell it today you would earn a total of  1,189  from holding Praxis Precision Medicines or generate 20.4% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Praxis Precision Medicines

Day One Biopharmaceu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Praxis Precision Med

Risk-Adjusted Performance

0 of 100

OK

Over the last 90 days Praxis Precision Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Day One and Praxis Precision

The main advantage of trading using opposite Day One and Praxis Precision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Praxis Precision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Praxis Precision will offset losses from the drop in Praxis Precision's long position.

The idea behind Day One Biopharmaceuticals and Praxis Precision Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.